76 related articles for article (PubMed ID: 38453197)
21. Controlling Nutritional Status (CONUT) as a Novel Postoperative Prognostic Marker in Breast Cancer Patients: A Retrospective Study.
Zhu M; Chen L; Kong X; Wang X; Ren Y; Liu Q; Li X; Fang Y; Wang J
Biomed Res Int; 2022; 2022():3254581. PubMed ID: 36531650
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of nutritional status in patients with human immunodeficiency virus infection-related lymphoma.
Liu T; Hu R; Lv J; Luo Q; Xu L; Wang C; Liu J; Yang Z; Xu L; Liu Y
Front Nutr; 2022; 9():1050139. PubMed ID: 36438738
[TBL] [Abstract][Full Text] [Related]
23. The prognostic role of controlling nutritional status and skeletal muscle mass in patients with hepatocellular carcinoma after curative treatment.
Tamai Y; Iwasa M; Eguchi A; Shigefuku R; Sugimoto R; Tanaka H; Kobayashi Y; Mizuno S; Nakagawa H
Eur J Gastroenterol Hepatol; 2022 Dec; 34(12):1269-1276. PubMed ID: 36317773
[TBL] [Abstract][Full Text] [Related]
24. Controlling Nutritional Status (CONUT) Score and Sarcopenia as Mutually Independent Prognostic Biomarkers in Advanced Urothelial Carcinoma.
Une M; Ito M; Suzuki H; Toide M; Kobayashi S; Fukushima H; Koga F
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291858
[TBL] [Abstract][Full Text] [Related]
25. Prognostic impact of the controlling nutritional status score in patients with hematologic malignancies: A systematic review and meta-analysis.
Lu C; Chen Q; Fei L; Wang J; Wang C; Yu L
Front Immunol; 2022; 13():952802. PubMed ID: 36275665
[TBL] [Abstract][Full Text] [Related]
26. Geriatric nutritional risk index as a prognostic factor in patients with recurrent pancreatic cancer.
Sakamoto T; Makinoya M; Sunaguchi T; Goto K; Morimoto M; Murakami Y; Miyatani K; Hanaki T; Shishido Y; Kihara K; Matsunaga T; Yamamoto M; Tokuyasu N; Fujiwara Y
PLoS One; 2022; 17(7):e0271073. PubMed ID: 35797279
[TBL] [Abstract][Full Text] [Related]
27. Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker in Unresectable or Metastatic Esophageal Cancer Patients With Anti-PD-1 Therapy.
Gao Y; Zhang Z; Li Y; Chen S; Lu J; Wu L; Ma Z; Hu Y; Zhang G
Front Oncol; 2022; 12():834564. PubMed ID: 35494073
[TBL] [Abstract][Full Text] [Related]
28. Targeted Drug Delivery and Theranostic Strategies in Malignant Lymphomas.
Etrych T; Braunova A; Zogala D; Lambert L; Renesova N; Klener P
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158894
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Value of Pretreatment Controlling Nutritional Status Score for Patients With Pancreatic Cancer: A Meta-Analysis.
Ma X; Zou W; Sun Y
Front Oncol; 2021; 11():770894. PubMed ID: 35127478
[TBL] [Abstract][Full Text] [Related]
30. Circulating Tumor DNA in Lymphoma: Principles and Future Directions.
Roschewski M; Rossi D; Kurtz DM; Alizadeh AA; Wilson WH
Blood Cancer Discov; 2022 Jan; 3(1):5-15. PubMed ID: 35015693
[TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of the controlling nutritional status score in patients with peripheral T-cell lymphoma.
Nakamura N; Kanemura N; Lee S; Fujita K; Morishita T; Takada E; Shibata Y; Kasahara S; Goto H; Fukuno K; Hara T; Yamada T; Sawada M; Tsurumi H; Shimizu M
Leuk Lymphoma; 2022 Jun; 63(6):1323-1330. PubMed ID: 34965828
[TBL] [Abstract][Full Text] [Related]
32. The Association of Controlling Nutritional Status (CONUT) Score with Survival in Patients with Surgically Treated Renal Cell Carcinoma and Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
Xue W; Hu X; Zhang Y
Nutr Cancer; 2022; 74(6):1907-1916. PubMed ID: 34490808
[TBL] [Abstract][Full Text] [Related]
33. The Utility of CONUT Score in Diffuse Large B Cell Lymphoma Patients.
Baysal M; Bas V; Demirci U; Gulsaran SK; Umit E; Kirkizlar HO; Demir AM
Niger J Clin Pract; 2021 Aug; 24(8):1194-1199. PubMed ID: 34397030
[TBL] [Abstract][Full Text] [Related]
34. The platelet to lymphocyte ratio is a potential inflammatory marker predicting the effects of adjuvant chemotherapy in patients with stage II colorectal cancer.
Fu Y; Chen X; Song Y; Huang X; Chen Q; Lv X; Gao P; Wang Z
BMC Cancer; 2021 Jul; 21(1):792. PubMed ID: 34238262
[TBL] [Abstract][Full Text] [Related]
35. Treatment resistance in diffuse large B-cell lymphoma.
He MY; Kridel R
Leukemia; 2021 Aug; 35(8):2151-2165. PubMed ID: 34017074
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Value of Peripheral Blood Lymphocyte/monocyte Ratio in Lymphoma.
Gao F; Hu J; Zhang J; Xu Y
J Cancer; 2021; 12(12):3407-3417. PubMed ID: 33995619
[No Abstract] [Full Text] [Related]
37. Is CONUT score a prognostic index in patients with diffuse large cell lymphoma?
Akgün Çağlıyan G; Hacıoğlu S; Ünver Koluman B; İlkkılıç K; Nar R; Başer MN; Bozdemir A; Şenol H; Şen Türk N; Erol V; Yılıdırım O; Çağlıyan Ö; Güler N
Turk J Med Sci; 2021 Aug; 51(4):2112-2119. PubMed ID: 33957727
[TBL] [Abstract][Full Text] [Related]
38. Consecutive Hypoalbuminemia Predicts Inferior Outcome in Patients With Diffuse Large B-Cell Lymphoma.
Wei X; Zheng J; Zhang Z; Liu Q; Zhan M; Huang W; Chen J; Wei Q; Wei Y; Feng R
Front Oncol; 2020; 10():610681. PubMed ID: 33585232
[TBL] [Abstract][Full Text] [Related]
39. Controlling nutritional status is a prognostic factor for patients with lung cancer: a systematic review and meta-analysis.
Zhang C; Li XK; Cong ZZ; Zheng C; Luo C; Xie K; Xu Y; Gu WF; Qiang Y; Shen Y
Ann Palliat Med; 2021 Apr; 10(4):3896-3905. PubMed ID: 33548999
[TBL] [Abstract][Full Text] [Related]
40. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
